Monthly Prescribing Reference

Extreme Insulin Requirements in Patient with Rare Genetic Disorder

Initially, the infusion was made using U-100 insulin; the hospital standardized the concentration of insulin drips (1 U/mL) in order to reduce medication errors. But concern was raised about excessive ...
Medscape

Implementation of Insulin Infusion Guidelines in a Neonatal Intensive Care Unit

Although the use of continuous insulin infusions in VLBW infants is well documented in the literature, few published hospital protocols are available. Furthermore, there are no comprehensive protocols ...
The American Journal of Managed Care

Subcutaneous Insulin Linked to Reduced Hospital Costs, LOS in Children With Mild DKA

Treating children with mild diabetic ketoacidosis (DKA) using subcutaneous (SC) insulin aspart was linked to lower hospital costs and better efficacy of DKA management, compared with using intravenous ...
Healio

Insulin infusion in gestational diabetes reduces neonatal hypoglycemia

Please provide your email address to receive an email when new articles are posted on . Neonatal hypoglycemia is common in infants born soon after betamethasone administration and may be reduced by at ...
Monthly Prescribing Reference

FDA Approves Myxredlin, a Ready-to-Use Insulin for IV Infusion

The FDA has approved Myxredlin (Baxter), the first ready-to-use insulin for intravenous (IV) infusion for use in acute care settings under medical supervision. The Food and Drug Administration (FDA) ...
Business Wire

Capillary Biomedical Receives $1.5 Million from Helmsley Charitable Trust for Clinical Trials of New Insulin Infusion Technology

IRVINE, Calif.--(BUSINESS WIRE)--Capillary Biomedical, Inc. (CapBio) has announced that it has received a $1.5 million program-related investment in the form of a loan from The Leona M. and Harry B.